Spinning molecular immunology into successful immunotherapy.
about
The role of NKT cells in tumor immunityInflammation and cancerProgrammed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancerCo-administration of a DNA vaccine encoding the prostate specific membrane antigen and CpG oligodeoxynucleotides suppresses tumor growthVaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialInterferon-gamma Added During Bacillus Calmette-Guerin Induced Dendritic Cell Maturation Stimulates Potent Th1 Immune ResponsesAllogeneic tumor cell vaccines: the promise and limitations in clinical trialsTargeting and utilizing primary tumors as live vaccines: changing strategiesClonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patientsSTATs in cancer inflammation and immunity: a leading role for STAT3Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs.A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell functionRapid maturation of effector T cells in tumors, but not lymphoid organs, during tumor regression.B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cellsRelationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosisOverexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors.Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells.Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses.Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cellsTargeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses.T cells take aim at cancerTowards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens.A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacyFunctional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.Chemotherapy and tumor immunity: an unexpected collaborationThe future of vaccination as a treatment strategy in dermatological diseases.The basis of T-cell-mediated immunity to chronic myelogenous leukemia.Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.Principles of tumor immunosurveillance and implications for immunotherapy.Therapeutic vaccination for the treatment of mucosotropic human papillomavirus-associated disease.Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion.How will HPV vaccines affect cervical cancer?An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.ALK a novel lymphoma-associated tumor antigen for vaccination strategies.Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta.Transgenic Eimeria mitis expressing chicken interleukin 2 stimulated higher cellular immune response in chickens compared with the wild-type parasites.Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope VaccineCurrent status and prospects for gene therapy.Anticancer immune reactivity and long-term survival after treatment of metastatic ovarian cancer with dendritic cells
P2860
Q24648939-BFD08672-6566-433C-B638-ACC3AFA15455Q24649640-75D17FAF-EEB6-44A4-8D74-E1B482315148Q24685406-8AC975F4-9FBC-4955-8275-667E2886EA00Q24794166-31BD703D-55A9-4605-8C43-B22B96CE09B2Q24801506-E3176132-A654-4F36-9457-CADAF904F80BQ24805658-24FAC763-BC5E-45F0-8BDB-63021433A2D5Q26852333-411F53F5-E0F5-4EA7-A2D7-35810EBD2269Q27009348-CE6181EA-1AFD-42D4-88A0-1E145FFADBABQ28742878-944DE0BD-63C4-4627-ADBD-90650B23F037Q29547203-33942D4C-C25A-4A9D-A67B-D56A2F44F58EQ30501320-B4B8BAE6-784D-40DE-8B77-B7D30C0F7730Q33281005-EB9DA7FA-0679-43AF-8414-B7A121177E35Q33296983-919E73F2-04C2-41AF-8160-A7AD20E0386AQ33592911-2ADED910-8CE0-4908-8B29-3B3CFCF271F1Q33788244-26B020EB-12F1-47CF-8E32-A6AC9AE88FB2Q33813057-66C54828-4A38-42A3-9B88-6ECAAB1FB8CFQ33928413-A7E8D6AE-1786-4152-9D44-57A40C2CE827Q34001211-C32E72F4-4D12-4965-9EA4-DF6111B8E1C7Q34022425-3D9416D8-BBCD-4838-A9B3-DCD88EB2E6E8Q34048648-D7F31B5A-CBE6-4308-8AEF-63549BC3F8DCQ34414412-996181EB-DCA2-4200-A5DF-B6C349F8122FQ34434814-416EEABF-D893-4ACD-A0ED-5FA6652811D2Q34590434-E5DAD4C2-D0B6-471F-ACA9-4F51ADA9E80DQ34755217-07D57983-BA07-4449-A50C-E9338D7D174BQ34764685-9DE48097-4329-4BF1-A353-619864DFB910Q34909777-8F71A3F6-341A-47EE-B767-DAC1DA05FAB4Q35015879-C78B29C3-5B1E-4B7D-8BF8-35E931D31E5AQ35022552-2E46F767-FA3E-4DD0-B8CD-53EF868461F3Q35043106-E89BFA07-4A22-4E83-95E4-C9322A7A8ABBQ35043113-59724CD4-6364-44B4-8BBC-221194D0F699Q35144042-D1A48C3B-BD17-46E7-9B67-6AEF63BE846EQ35210490-2DB65B56-0451-4DCA-84B0-0BD109DA8C64Q35235035-2FCD2FAD-0149-48D3-A9A7-748748EDF0FAQ35266959-41979D19-070C-4148-B1F5-8FF912692C48Q35614635-149346F3-FB77-4D55-AF67-78232D04F7E9Q35615827-E70F16D2-8156-433F-9255-6FFB0B1B2148Q35672493-70DC1BEA-ECB6-42F0-839B-CA40FBF41F31Q35782058-42729BBB-7466-4A95-ADC4-1AB6F0648D4CQ35881934-620FA9ED-854D-4F7A-9886-252FA85ADA0EQ35995520-4E710F9A-F898-4F23-825B-19884C2060C1
P2860
Spinning molecular immunology into successful immunotherapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Spinning molecular immunology into successful immunotherapy.
@ast
Spinning molecular immunology into successful immunotherapy.
@en
Spinning molecular immunology into successful immunotherapy.
@nl
type
label
Spinning molecular immunology into successful immunotherapy.
@ast
Spinning molecular immunology into successful immunotherapy.
@en
Spinning molecular immunology into successful immunotherapy.
@nl
prefLabel
Spinning molecular immunology into successful immunotherapy.
@ast
Spinning molecular immunology into successful immunotherapy.
@en
Spinning molecular immunology into successful immunotherapy.
@nl
P2860
P356
P1476
Spinning molecular immunology into successful immunotherapy.
@en
P2093
Drew M Pardoll
P2860
P304
P356
10.1038/NRI774
P577
2002-04-01T00:00:00Z